Armata Pharmaceuticals Inc (ARMP)
2.25
+0.15
(+7.14%)
USD |
NYAM |
Nov 22, 16:00
2.25
0.00 (0.00%)
After-Hours: 20:00
Armata Pharmaceuticals Free Cash Flow: -42.09M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -42.09M |
| June 30, 2024 | -46.08M |
| March 31, 2024 | -46.82M |
| December 31, 2023 | -55.57M |
| September 30, 2023 | -55.09M |
| June 30, 2023 | -53.52M |
| March 31, 2023 | -50.52M |
| December 31, 2022 | -34.69M |
| September 30, 2022 | -33.49M |
| June 30, 2022 | -27.41M |
| March 31, 2022 | -22.86M |
| December 31, 2021 | -24.88M |
| September 30, 2021 | -22.72M |
| June 30, 2021 | -21.14M |
| March 31, 2021 | -20.53M |
| December 31, 2020 | -19.09M |
| September 30, 2020 | -15.18M |
| June 30, 2020 | -15.72M |
| March 31, 2020 | -17.54M |
| December 31, 2019 | -15.81M |
| September 30, 2019 | -14.57M |
| June 30, 2019 | -12.24M |
| Date | Value |
|---|---|
| March 31, 2019 | -8.491M |
| December 31, 2018 | -9.426M |
| September 30, 2018 | -10.30M |
| June 30, 2018 | -8.753M |
| March 31, 2018 | -9.482M |
| December 31, 2017 | -9.25M |
| September 30, 2017 | -8.374M |
| June 30, 2017 | -10.91M |
| March 31, 2017 | -10.99M |
| December 31, 2016 | -10.88M |
| September 30, 2016 | -11.74M |
| June 30, 2016 | -11.19M |
| March 31, 2016 | -10.85M |
| December 31, 2015 | -9.991M |
| September 30, 2015 | -10.83M |
| June 30, 2015 | -10.98M |
| March 31, 2015 | -12.19M |
| December 31, 2014 | -13.77M |
| September 30, 2014 | -11.99M |
| June 30, 2014 | -11.75M |
| March 31, 2014 | -9.195M |
| December 31, 2013 | -6.292M |
Free Cash Flow Range, Past 5 Years
-55.57M
Minimum
Dec 2023
-15.18M
Maximum
Sep 2020
-32.04M
Average
-26.14M
Median
Free Cash Flow Benchmarks
| AIM ImmunoTech Inc | -21.33M |
| Perspective Therapeutics Inc | -40.58M |
| Protalix BioTherapeutics Inc | 7.171M |
| Electromed Inc | 11.30M |
| Xtant Medical Holdings Inc | -17.28M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.863M |
| Cash from Investing (Quarterly) | -0.34M |
| Cash from Financing (Quarterly) | -0.061M |
| Free Cash Flow Per Share (Quarterly) | -0.2544 |
| Free Cash Flow Yield | -44.90% |